Pediatric IPEX-Associated Dermatitis Responds To Dupilumab: Evidence from Skin Transcriptomics and Immune Profiling
Published by
J Clin Immunol
Summary
Co-first author in a study published in a Q1 journal (IF=5.7), providing transcriptomic and immune profiling evidence for Dupilumab's efficacy in pediatric IPEX-associated dermatitis (PubMed PMID: 41653277).